Pusan, South Korea -- Intralesional interferon alfa-2b (Intron-A) can be a useful option for the treatment of rapidly growing keratoacanthomas, Chang-Keun Oh, M.D., Ph.D., said.
First Study Reveals Covariate-Adjusted Effects of New Actinic Keratosis Therapies for Face and Scalp
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Physicians Should Prepare for Potential Acne Vulgaris Misinformation Correction, Report Says
The Cutaneous Connection: Enhancing Vitiligo Care With Nanette Silverberg, MD
Managing Food Allergies with Dupilumab in Pediatric Dermatology
Latex Gloves and the Americans With Disabilities Act